Abstract:Human islet amyloid polypeptide (hIAPP or amylin) is a causative agent in pancreatic amyloid deposits found in patients with type 2 diabetes. The aggregation of full-length hIAPP(1-37) into small oligomeric species is increasingly believed to be responsible for cell dysfunction and death. However, rat IAPP (rIAPP(1-37)), which differs from hIAPP in only six of 37 residues, loses its aggregation ability to form toxic amyloid species. Atomic details of the effect of sequence on the structure and toxicity between the amyloidogenic, toxic hIAPP peptide and the nonamyloidogenic, nontoxic rIAPP peptide remain unclear. Here, we probe sequence-induced differences in structural stability, conformational dynamics, and driving forces between different hIAPP and rIAPP polymorphic forms from monomer to pentamer using molecular dynamics simulations. Simulations show that hIAPP forms from trimer to pentamer exhibit high structural stability with well-preserved in-register parallel beta-sheet and the U-bend conformation. The hIAPP trimer appears to be a smallest minimal seed in solution. The stabilities of parallel hIAPP oligomers increase with the number of peptides. Conversely, replacement of hIAPP sequence by rIAPP sequence causes a significant loss of favorable interpeptide interactions in all rIAPP oligomers, destabilizing the C-terminal beta-sheet, turn conformation, and overall stability. A less beta-sheet-rich structure and a disturbed U-shaped topology exert a large energy penalty on the self-assemble of the rIAPP peptides into highly ordered, in-register beta-sheet-rich protofibrils and fibrils, which explains the nonamyloidogenic activity of rIAPP. Moreover, the absence of interior water within the U-turn region in the well-packed higher-order hIAPP oligomers, not in the poorly packed rIAPP oligomers, also stabilizes peptide association. This work provides atomic details of the sequence-structure relationship between the amyloidogenic hIAPP and its analogues such as the nonamyloidogenic rIAPP and some mutants, which could help in the development of novel therapeutic agents to block the formation of toxic hIAPP oligomeric species for type 2 diabetes.

Breakout character of islet amyloid polypeptide hydrophobic mutations at the onset of type-2 diabetes

Cross-Seeding Interaction Between Β-Amyloid and Human Islet Amyloid Polypeptide.

Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.

The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide*

Elucidating conformational alteration of human islet amyloid polypeptide by nonsynonymous substitution

Interspecies Variation Affects Islet Amyloid Polypeptide Membrane Binding

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Deciphering the Molecular Dance: Exploring the Dynamic Interplay Between Mouse Insulin B9-23 Peptides and Their Variants

Residual Structure in Islet Amyloid Polypeptide Mediates Its Interactions with Soluble Insulin.

Dynamics of the Conformational Transitions During the Dimerization of an Intrinsically Disordered Peptide: A Case Study on the Human Islet Amyloid Polypeptide Fragment

Human islet amyloid polypeptide-induced β-cell cytotoxicity is linked to formation of α-sheet structure

Influence of Force Field Choice on the Conformational Landscape of Rat and Human Islet Amyloid Polypeptide

Islet amyloid polypeptide tagged with green fluorescent protein localises to mitochondria and forms filamentous aggregates in Caenorhabditis elegans

Recent Progress of Islet Amyloid Polypeptide

Lipid Interaction And Membrane Perturbation Of Human Islet Amyloid Polypeptide Monomer And Dimer By Molecular Dynamics Simulations

Ph-Dependent Interactions Of Human Islet Amyloid Polypeptide Segments With Insulin Studied By Replica Exchange Molecular Dynamics Simulations

Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors

Aspects of structural landscape of human islet amyloid polypeptide

Metabolic perturbations associated with hIAPP-induced insulin resistance in skeletal muscles: Implications to the development of type 2 diabetes

Structural characterization and cryo-electron tomography analysis of human islet amyloid polypeptide suggest a synchronous process of the hIAPP1−37 amyloid fibrillation

Structural Effects of L16Q, S20G, and L16Q‐S20G Mutations on hIAPP: A Comparative Molecular Dynamics Study